FDA Considers Sequencing for Quality-Control Testing of Vaccines

An FDA advisory committee acknowledged that next-generation sequencing is a powerful tool for ensuring vaccines are free of harmful contaminants, while expressing concerns about data interpretation as well as the challenges of implementing a regulatory framework for sequencing-based vaccine QC.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.